Literature DB >> 10418983

Progesterone as a neurosteroid: synthesis and actions in rat glial cells.

I Jung-Testas1, A Do Thi, H Koenig, F Désarnaud, K Shazand, M Schumacher, E E Baulieu.   

Abstract

The central nervous system (CNS) and the peripheral nervous system (PNS) are targets for steroid hormones where they regulate important neuronal functions. Some steroid hormones are synthesized within the nervous system, either de novo from cholesterol, or by the metabolism of precursors originating from the circulation, and they were termed 'neurosteroids'. The sex steroid progesterone can also be considered as a neurosteroid since its synthesis was demonstrated in rat glial cell cultures of the CNS (oligodendrocytes and astrocytes) and of the PNS (Schwann cells). Both types of glial cells express steroid hormone receptors, ER, GR and PR. As in target tissue, e.g. the uterus, PR is estrogen-inducible in brain glial cell cultures. In the PNS, similar PR-induction could not be seen in pure Schwann cells derived from sciatic nerves. However, a significant PR-induction by estradiol was demonstrated in Schwann cells cocultured with dorsal root ganglia (DRG), and we will present evidence that neuronal signal(s) are required for this estrogen-mediated PR-induction. Progesterone has multiple effects on glial cells, it influences growth, differentiation and increases the expression of myelin-specific proteins in oligodendrocytes, and potentiates the formation of new myelin sheaths by Schwann cells in vivo. Progesterone and progesterone analogues also promotes myelination of DRG-Neurites in tissue culture, strongly suggesting a role for this neurosteroid in myelinating processes in the CNS and in the PNS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10418983     DOI: 10.1016/s0960-0760(98)00149-6

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  20 in total

Review 1.  Progesterone treatment of spinal cord injury: Effects on receptors, neurotrophins, and myelination.

Authors:  Alejandro F De Nicola; Susana L Gonzalez; Florencia Labombarda; Maria Claudia González Deniselle; Laura Garay; Rachida Guennoun; Michael Schumacher
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.

Authors:  Stephanie J Byer; Jenell M Eckert; Nicole M Brossier; Buffie J Clodfelder-Miller; Amy N Turk; Andrew J Carroll; John C Kappes; Kurt R Zinn; Jeevan K Prasain; Steven L Carroll
Journal:  Neuro Oncol       Date:  2010-11-12       Impact factor: 12.300

3.  Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex.

Authors:  M Singh
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

4.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

Review 5.  Management of the extremely preterm infant: is the replacement of estradiol and progesterone beneficial?

Authors:  A Trotter; L Maier; F Pohlandt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Progestin concentrations are increased following paced mating in midbrain, hippocampus, diencephalon, and cortex of rats in behavioral estrus, but only in midbrain of diestrous rats.

Authors:  Cheryl A Frye; Madeline E Rhodes
Journal:  Neuroendocrinology       Date:  2006-10-04       Impact factor: 4.914

7.  Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis.

Authors:  H Sakamoto; K Ukena; K Tsutsui
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Estradiol and Progesterone Administration After pMCAO Stimulates the Neurological Recovery and Reduces the Detrimental Effect of Ischemia Mainly in Hippocampus.

Authors:  Maria Jose Perez-Alvarez; Laura Mateos; Alvaro Alonso; Francisco Wandosell
Journal:  Mol Neurobiol       Date:  2014-11-07       Impact factor: 5.590

9.  SRC-1 is involved in the control of the gene expression of myelin protein Po.

Authors:  Ilaria Teresa Rita Cavarretta; Luciano Martini; Marcella Motta; Carolyn Louise Smith; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Membrane estrogen receptor-alpha interacts with metabotropic glutamate receptor type 1a to mobilize intracellular calcium in hypothalamic astrocytes.

Authors:  John Kuo; Omid R Hariri; Galyna Bondar; Julie Ogi; Paul Micevych
Journal:  Endocrinology       Date:  2008-10-23       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.